相关实验视频

Updated: Sep 11, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

准髓状细胞以改善癌症免疫疗法

Hui Chen^1,2, Zihan Xu¹, Judith Varner^1,2

¹Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States.

Frontiers in immunology

|August 18, 2025

概括

向瘤微环境 (TME) 中的髓状细胞可以克服癌症免疫疗法耐药性. 策略重点关注重点途径和分子来重编程TME并提高抗瘤免疫力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

瘤免疫抑制是癌症免疫治疗中的一个主要障碍.
天生的免疫细胞,特别是瘤微环境 (TME) 中的髓状细胞,驱动免疫抑制和瘤进展.
了解髓状细胞生物学提供了新的治疗点.

研究的目的:

审查关键的信号通路和涉及骨髓介导免疫抑制的表面分子.
检查针对这些途径的临床前和临床证据.
讨论骨髓细胞向策略作为癌症免疫治疗的辅助手段的潜力.

主要方法:

关于骨髓状细胞生物学和癌症免疫治疗的当前文献的审查.
对信号通路 (例如,CSF1R,PI3Kγ,mTOR,Syk,MerTK/Axl) 和免疫检查点 (例如,Trem2,LILRBs,VISTA,CD40) 的分析.
检查与针对这些机制相关的临床前和临床发现.

主要成果:

骨髓状细胞群 (TAMs,MDSCs等等) 的情况. 它们在抑制抗瘤免疫力方面起着至关重要的作用.
特定的途径和分子被确定为骨髓介导免疫抑制的关键驱动因素.
针对这些途径在临床前和临床研究中显示出重编程TME的前景.

结论:

骨髓状细胞向策略是增强当前癌症免疫疗法的有希望的方法.
通过调节髓状细胞功能来重新编程TME可以改善抗瘤免疫力.
需要进一步的研究才能将这些发现转化为持久的临床益处.

关键词:

在 Axl Axl 轴上 CSF1R (殖民地刺激因子1受体)在LILRBB里.在PI3Kgamma中.在TREM2中,我们可以使用TREM2.免疫抑制是一种免疫抑制.骨髓状细胞细胞是什么?瘤相关的巨细胞 (TAM)

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...